Research highlights dornase alfa's effectiveness in reducing inflammation in COVID-19 patients.
― 7 min read
Cutting edge science explained simply
Research highlights dornase alfa's effectiveness in reducing inflammation in COVID-19 patients.
― 7 min read
Fluoxetine shows modest antiviral effects against COVID-19 but is not a primary treatment option.
― 6 min read
A review of COVID-19 mRNA vaccines' effects on children's health.
― 5 min read
A review of randomized controlled trials on hydroxychloroquine for Covid-19.
― 6 min read
New methods enhance treatment selection in clinical trials for improved patient care.
― 6 min read
A new framework helps researchers assess treatment crossover effects in clinical trials.
― 6 min read
Study examines treatment interruption strategies for managing HIV without antiretroviral therapy.
― 7 min read
Research aims to lower severe side effects in rectal cancer treatment with chlorophyllin.
― 6 min read
A deeper look into effective methods for analyzing health outcomes over time.
― 8 min read
This article examines the impact of treatments on diverse patient subgroups using multi-source data.
― 6 min read
Examining how clinical trial findings apply to broader patient care.
― 6 min read
A review reveals the need for better clinical trial reporting in the Nordic region.
― 6 min read
Researchers create synthetic data to project long-term outcomes of Alzheimer's treatments.
― 5 min read
The Solidarity Finland trial evaluates imatinib's effectiveness in COVID-19 treatment.
― 5 min read
Addressing the challenge of privacy in data-driven decision-making for healthcare.
― 6 min read
Examining the varied impacts of SSRIs on different depression symptoms.
― 6 min read
Explore the crucial role of algorithm fidelity in online reinforcement learning for healthcare trials.
― 7 min read
Examining methods to ensure fair comparisons in small clinical trials.
― 5 min read
Exploring innovative approaches in survival analysis for better data insights.
― 6 min read
Research explores HER2's role in prostate cancer resistance and potential treatment strategies.
― 6 min read
Research reveals significant genetic changes in stem cells during lab culture.
― 4 min read
Innovative approaches tackle challenges in comparing treatment effects over time.
― 6 min read
AI aids in participant recruitment for age-related macular degeneration trials.
― 6 min read
This study investigates how immune markers relate to various mental health conditions.
― 6 min read
A method to ensure balanced groups in experiments for fair results.
― 6 min read
TrialEmulation helps researchers analyze treatment effects using observational data.
― 7 min read
ComMAND offers precise control over gene expression for safer therapies.
― 5 min read
Improving transparency is vital for credible scientific research and reliable findings.
― 7 min read
A fresh approach to improving treatment effect estimation in clinical research.
― 6 min read
A fresh perspective on testing medical treatments aims for clearer results.
― 6 min read
Nivolumab shows promise in treatment, but cost-effectiveness raises concerns.
― 5 min read
A new approach to dose-finding trials enhances efficiency and accuracy in drug development.
― 6 min read
Research dives into factors affecting immune checkpoint inhibitors in bladder cancer treatment.
― 8 min read
This article examines the changing success rates of drugs in clinical trials.
― 7 min read
Clear guidelines for reporting transcranial ultrasound studies enhance research reliability.
― 6 min read
A new approach enhances the measurement of risks in clinical trials.
― 4 min read
A study assesses the reporting quality of multi-country randomized controlled trials involving Ireland.
― 6 min read
Hydroporation enhances CAR-T cell therapy by improving T-cell viability and targeting effectiveness.
― 7 min read
New method improves safety and reliability in drug trial dosing.
― 7 min read
A look at methods for accurately assessing treatment impacts.
― 7 min read